Absolute neutrophil count (ANC) > 1500/mm^3 =< 2 weeks prior to randomizationXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500 mm^3, must be obtained within 8 weeks prior to screening for protocol therapyXx_NEWLINE_xXELIGIBILITY CRITERIA FOR RANDOMIZATION (STEP 1): Absolute neutrophil count (ANC) > 1500 mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1500/uL; Note: no transfusions are permitted 7 days prior to laboratory studies to determine eligibilityXx_NEWLINE_xXAbsolute neutrophil count >= 1500 cells/mm^3Xx_NEWLINE_xXObtained within 28 days prior randomization: absolute neutrophil count (ANC) must be >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1500/mm^3Xx_NEWLINE_xXAbsolute granulocytes >= 1500 cells/uL (1.5 x 10^9 L)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.5 x 10^9/L (1500/mm3)Xx_NEWLINE_xXObtained =< 21 days prior to registration: Absolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXANC ? 1500/mm3Xx_NEWLINE_xXAbsolute neutrophil count > 1500/µLXx_NEWLINE_xXAbsolute neutrophil count >= 1500/mm^3Xx_NEWLINE_xXObtained =< 14 days prior to registration: Absolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1500 cells/?LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uL, within 14 days of registrationXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) 1500/mm^3 within 3 weeks prior to study registration; blood transfusion to meet the inclusion criteria will not be allowedXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXANC < 1500/ulXx_NEWLINE_xXAbsolute neutrophil count ?1500/µL.Xx_NEWLINE_xXAbsolute neutrophil count > 1500 cells/mcLXx_NEWLINE_xXAbsolute neutrophil count (ANC) greater than or equal to 1500/µLXx_NEWLINE_xXAbsolute neutrophil count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1500 per mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 unless due to direct bone marrow involvement of diseaseXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 obtained =< 14 days prior to registrationXx_NEWLINE_xXThe absolute neutrophil count (ANC) >= 1500/mm^3 without colony stimulating factor support within 7 days before the first dose of cabozantinibXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1500/mm^3Xx_NEWLINE_xXWithin 10 (except as noted) days of planned treatment initiation: Absolute neutrophil count (ANC) >= 1.5 x 10^9/L (>= 1500 per mm^3)Xx_NEWLINE_xXANC must be ? 1500/mm3;Xx_NEWLINE_xXAbsolute neutrophil count 1500/ul or moreXx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1500/millimeters cubed (mm^3) (?1.5 × 10^9/Liters [L]);Xx_NEWLINE_xXObtained =< 2 weeks prior to registration: Absolute neutrophil count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uL performed within 30 days prior to the date of registrationXx_NEWLINE_xXAbsolute neutrophil count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/mm^3 (1.5 x 10^9/L)Xx_NEWLINE_xXAbsolute neutrophil count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXObtained =< 35 days prior to registration: absolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uL (with/without growth factor)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (>= 1500 per mm^3)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500 cells/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC): >= 1500/mcLXx_NEWLINE_xXARM 2 - A: ANC: >= 1500/mcLXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500/mm^3Xx_NEWLINE_xXPHASE I: Absolute neutrophil count >= 1500/uLXx_NEWLINE_xXPHASE IB: Absolute neutrophil count >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3 is necessary; blood transfusion to meet the inclusion criteria will not be allowedXx_NEWLINE_xXOBTAINED =< 7 DAYS PRIOR TO REGISTRATION: Absolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3 obtained =< 28 days prior to registrationXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uL.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/uL.Xx_NEWLINE_xXShould be performed within 10 days of treatment initiation: absolute neutrophil count (ANC) ? 1.5 x 10^9/L (?1500 per mm^3)Xx_NEWLINE_xXARM I&II: Absolute neutrophil count (ANC) > 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500/lXx_NEWLINE_xXAbsolute neutrophil count ?1500/mm3Xx_NEWLINE_xXWithin 10 days prior to the start of study treatment: Absolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXNeutrophil count of > 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) less than 1500/mm^3Xx_NEWLINE_xXObtained =< 14 days prior to registration: Absolute neutrophil count (ANC) >= 1500 uLXx_NEWLINE_xXWithin 28 days prior to treatment start: Absolute neutrophil count (ANC) >= 1500/ulXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3 (measured within 28 days of registration)Xx_NEWLINE_xXAbsolute neutrophil count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXANC* ? 1500/mm³ (? 1.5 x 10^9/L)Xx_NEWLINE_xXSTUDY TREATMENT: Absolute neutrophil count (ANC) >= 1500 cells/uL within 14 days prior to the first study treatment.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1.5 x 10^9/L (> 1500 per mm^3)Xx_NEWLINE_xXObtained within 28 days prior to the first dose of cabozantinib: absolute neutrophil count (ANC) >= 1500/mm^3 without colony stimulating factor support.Xx_NEWLINE_xXAbsolute neutrophil count 1500/ul or moreXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (>= 1500 /uL)Xx_NEWLINE_xXWithin 4 weeks of day 1: Absolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 ulXx_NEWLINE_xXAbsolute neutrophil count 1500/ul or moreXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 ul.Xx_NEWLINE_xXObtained within 14 days of the first study treatment: Absolute neutrophil count (ANC) > 1500 cells/ulXx_NEWLINE_xXAbsolute neutrophil count >= 1500/uLXx_NEWLINE_xXObtained =< 14 days prior to registration: Absolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXObtained =< 14 days prior to registration: Absolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (>= 1500 per mm^3)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (> 1500 per mm^3)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L or at least 1500/mm^3 or at least 1.5 x 10^9/LXx_NEWLINE_xXObtained within 14 days of the first study treatment: Absolute neutrophil count (ANC) > 1500 cells/ulXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (>= 1500 per mm^3)Xx_NEWLINE_xXWithin 7 days before the first dose of study treatment: The absolute neutrophil count (ANC) >= 1500/mm^3 without colony stimulating factor supportXx_NEWLINE_xXAbsolute neutrophil count >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (> 1500 per mm^3).Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/uLXx_NEWLINE_xXObtained =< 28 days prior to registration: Absolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1500/?LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/ul within 14 days of cycle 1 day 1Xx_NEWLINE_xXObtained within 14 days prior to the first study treatment (cycle 1, day 1): absolute neutrophil count (ANC) >= 1500 cells/uXx_NEWLINE_xXNeutrophil count of > 1500/mm^3Xx_NEWLINE_xXabsolute neutrophil count (ANC) >= 1500/ulXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (> 1500 per mm^3)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1500/millimeters cubed (mm^3) (?1.5 × 10^3/microliters [µL])Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (>= 1500 per mm^3)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1500 cells/mm^3 at the time of screeningXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (> 1500 per mm^3)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >=1.5 x 10^9/L (>= 1500 per mm^3)Xx_NEWLINE_xXAbsolute neutrophil count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count greater than 1500/mm^3 without the support of filgrastimXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uL obtained =< 14 days prior to registrationXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (>= 1500 per mm^3)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3; blood transfusion to meet the inclusion criteria will not be allowedXx_NEWLINE_xXAbsolute neutrophil count [ANC] >= 1500 cells/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3 (1.5 x 10^9/L)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (>= 1500 per mm^3)Xx_NEWLINE_xXNeutrophil >1500/mm3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3 obtained =< 7 days prior to registrationXx_NEWLINE_xXPatients must have an absolute neutrophil count (ANC) greater than or equal to 1500/uLXx_NEWLINE_xXAbsolute neutrophil count >= 1500/mL.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/ulXx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXGranulocyte count > 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/mlXx_NEWLINE_xXNeutrophil count >= 1500 uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (> 1500 per mm^3).Xx_NEWLINE_xXWithin 14 days prior to the first study treatment (cycle 1, day 1): Absolute neutrophil count (ANC) >= 1500 cells/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 mm^3Xx_NEWLINE_xXANC >/=1500 cells/mcL (Cohort C)Xx_NEWLINE_xXPeripheral absolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1500 cells/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/uL (obtained within 28 days prior to first study treatment)Xx_NEWLINE_xXWithin 14 days of registration: Absolute neutrophil count (ANC) >= 1500/ulXx_NEWLINE_xXAbsolute neutrophil count >= 1500 per microliterXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (>= 1500 per mm^3) within 28 days prior to study registrationXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uL; filgrastim can be given before and during treatment to achieve target ANC >= 1500 uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1500 cells/uL within 14 days prior to the first study treatment (cycle 1, day 1)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3, obtained =< 14 days prior to registrationXx_NEWLINE_xXObtained =< 7 days prior to registration: Absolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3 obtained =< 14 days prior to registrationXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (>= 1500 per mm^3)Xx_NEWLINE_xXAbsolute neutrophil count >= 1500 mcLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (>= 1500 per mm^3)Xx_NEWLINE_xXAbsolute neutrophil count <1.5 x 10^9/L (<1500/mm3)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/mm^3Xx_NEWLINE_xXANC ?1500/mcLXx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1.5 x 10^9/L (1500 per mm^3)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1500/mLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (>= 1500 per mm^3)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (> 1500 per mm^3)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/uLXx_NEWLINE_xXObtained =< 14 days prior to randomization: Absolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count [ANC] < 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXCompleted within 60 days of surgery: Absolute neutrophil count (ANC) ? 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count ? 1500/?LXx_NEWLINE_xXAbsolute neutrophil count (ANC) or atypical glandular cell (AGC) >= 1500 per uLXx_NEWLINE_xXAbsolute neutrophils >= 1500/mm^3, within 14 day prior to registrationXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/ulXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (> 1500 per mm^3)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (>= 1500 per mm^3)Xx_NEWLINE_xXObtained =< 14 days prior to registration: Absolute neutrophil count (ANC) >= 1500Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1500/LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uL, without cerebrospinal fluid (CSF) supportXx_NEWLINE_xXLeukocytes absolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.5 x 10^9/L (? 1500 per mm^3)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1500/?lXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/uLXx_NEWLINE_xXAbsolute neutrophil count greater than or equal to 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/uLXx_NEWLINE_xXAbsolute neutrophil count < 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3, obtained =< 7 days prior to registrationXx_NEWLINE_xXWithin 14 days prior to study entry: Absolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1500 per mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1500/mm^3Xx_NEWLINE_xXADDITIONAL CRITERIA FOR STUDY CONTINUATION: Absolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mcLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/?LXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500/lXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/ulXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells per mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXThe absolute neutrophil count (ANC) count >= 1500Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/mm^3 prior to biopsyXx_NEWLINE_xXWithin 4 days prior to the first dose of cabozantinib: Absolute neutrophil count (ANC) >= 1500/mm^3 without colony stimulating factor supportXx_NEWLINE_xXGranulocyte count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/mm^3 or >= 1.5 bil/LXx_NEWLINE_xXAbsolute neutrophil count of >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count =< 1500 per mm^3Xx_NEWLINE_xXWithin 2 weeks of enrollment: Absolute neutrophil count, >= 1500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1500/uLXx_NEWLINE_xXAbsolute neutrophil count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count < 1500/mm3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 0.5 x 10^9/L (1500/mm^3)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/mm^3 (1.5 × 10^9/L)Xx_NEWLINE_xXAbsolute neutrophil count >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uL (obtained =< 7 days prior to registration)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3 without colony stimulating factor supportXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count of >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1500/mm3Xx_NEWLINE_xXANC <1500/?LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mcL (1.5 x 10^9/L) obtained within 2 weeks prior to registrationXx_NEWLINE_xXNeutrophil count of > 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1500 per mm^3 ANDXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500, unless due to direct bone marrow involvement of diseaseXx_NEWLINE_xXGranulocyte count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/mm^3 or >= 1.5 bil/LXx_NEWLINE_xXAbsolute neutrophil count >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1500/mm3Xx_NEWLINE_xXAbsolute neutrophil count of >= 1500/mm^3Xx_NEWLINE_xXPeripheral absolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXPeripheral absolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3 obtained =< 14 days prior to registrationXx_NEWLINE_xXObtained =< 28 days prior to randomization:\r\nAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1500/mm3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/cu mmXx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3, obtained =< 14 days prior to registrationXx_NEWLINE_xXAbsolute neutrophil counts ? 1500 cells/ mm3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/ulXx_NEWLINE_xXANC 1500 cells/?lXx_NEWLINE_xXAbsolute neutrophil count ? 1500/?LXx_NEWLINE_xXAbsolute neutrophil count (ANC)>1500/mm3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/ulXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXANC ?1500 cells/mm3Xx_NEWLINE_xXAbsolute neutrophil count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count ?1500 cells/mm3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1500 /µLXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500, unless due to direct bone marrow involvement of diseaseXx_NEWLINE_xXWithin 14 days of study drug(s) initiation: Absolute neutrophil count (ANC) >=1500/·L.Xx_NEWLINE_xXWithin 14 days prior to the first study treatment (cycle 1, day 1): Absolute neutrophil count (ANC) >= 1500 cells/uL.Xx_NEWLINE_xXAbsolute neutrophil count >= 1500/mLXx_NEWLINE_xXFor high risk and very high risk CLL-IPI (Arms A and B) only; obtained ? 30 days prior to randomization: Absolute neutrophil count (ANC) ? 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/mm^3 within 28 days prior to registration.Xx_NEWLINE_xXAbsolute neutrophil count >= 1500/mLXx_NEWLINE_xXAbsolute neutrophils >= 1500/mm^3.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1500/microliterXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 /mcLXx_NEWLINE_xXRENAL COHORT: Laboratory values as follows within 4 days before the first dose of daratumumab: The absolute neutrophil count (ANC) ? 1500/mm^3 without colony stimulating factor supportXx_NEWLINE_xXAbsolute neutrophil count =< 1500/mm^3.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1500/mm^3Xx_NEWLINE_xXGranulocyte count ? 1500/mm^3 ? 2 weeksXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1500 cells/mm^3 ? 2 weeksXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXObtained =< 21 days prior to registration: Absolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (> 1500 per mm^3) except for patients with HCC for whom ANC >= 1000 per mm^3 is allowedXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (> 1500 per mm^3)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/µLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/mm^3Xx_NEWLINE_xXObtained =< 7 days prior to registration: Absolute neutrophil count >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count >= 1500 cells/uL, obtained within 14 days prior to the first study treatment (cycle 1, day 1)Xx_NEWLINE_xXTo be performed within 28 days prior to day 1 of protocol therapy: Absolute neutrophil count (ANC) >= 1500/mm^3\r\n* NOTE: Growth factor is not permitted within 14 days of ANC assessment unless cytopenia is secondary to disease involvementXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3 (1.50 x 10^9 /L) obtained =< 28 days prior to registrationXx_NEWLINE_xXWithin 28 days of study registration: Absolute neutrophil counts >= 1500 cell/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3, unless secondary to bone marrow involvement; obtained =< 7 days prior to registrationXx_NEWLINE_xXPerformed within 14 days prior to study: Absolute neutrophil count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count >= 1500 cells/mm^3, obtained within 14 days prior to registration for protocol therapyXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count >= 1500/mcLXx_NEWLINE_xXAbsolute neutrophil count 1500/ul or moreXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3 or >= 1.5 x 10^9/L, obtained =< 14 days prior to registrationXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (>= 1500 per mm^3)Xx_NEWLINE_xXAbsolute neutrophil count >= 1500/mcLXx_NEWLINE_xXPeripheral absolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells per mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) => 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3, without colony stimulating factor supportXx_NEWLINE_xXPatients must have adequate hematologic reserve as evidenced by absolute neutrophil count (ANC) >= 1500/mm^3 and platelets >= 100,000/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute Neutrophil Count (ANC) >= 1500 per mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uL, specimens must be collected within 10 days prior to the start of study treatmentXx_NEWLINE_xXAbsolute neutrophil count greater than 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count of > 1500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3 (obtained =< 14 days prior to registration)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500/mm^3Xx_NEWLINE_xXWithin 14 days of subject registration: Absolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count greater than 1500/mm^3 without the support of filgrastimXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute-neutrophil count (ANC ) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1500/mLXx_NEWLINE_xXAbsolute neutrophil count ?1500/mm3;Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/ul (without growth factor support)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >1500 cells/mm3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1500/ulXx_NEWLINE_xXNeutropenia (absolute neutrophil count < 1500 cells/µL)Xx_NEWLINE_xXAbsolute neutrophil count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500Xx_NEWLINE_xXAbsolute neutrophil count (ANC) must be greater than or equal to 1500/mm3;Xx_NEWLINE_xXSUB-PROTOCOL AIM A: Absolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count/absolute granulocyte count ?1500/uLXx_NEWLINE_xXAbsolute neutrophil count ?1500 cells/ml,Xx_NEWLINE_xXAbsolute neutrophil count ? 1500 cells/mm3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/mm^3 within 14 days prior to study registrationXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3; blood transfusion to meet the inclusion criteria will not be allowedXx_NEWLINE_xXAbsolute neutrophil count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count ? 1500/mm3Xx_NEWLINE_xXANC ?1500/?LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/ulXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1500/ml, and/orXx_NEWLINE_xXAbsolute neutrophil count (ANC) >=1500/microlitre (uL).Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells per mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXANC ? 1500 /?LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXANC ? 1500 cells/µLXx_NEWLINE_xXWithin 14 days of enrollment: Absolute neutrophil count >= 1500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3 (within 14 days prior to day 1 of protocol therapy)Xx_NEWLINE_xXAbsolute neutrophil count >= 1500 /uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1.5 x 10^9/L (1500/mm3)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/ulXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1500/?L.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500Xx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1500/mlXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3; blood transfusion to meet the inclusion criteria will not be allowedXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 X 10^9/L (> 1500 per mm^3), obtained within 14 days prior to first treatmentXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count < 1.5 x109/L (< 1500 cells/mm3)Xx_NEWLINE_xXWithin 14 days prior to the first study treatment (cycle 1, day 1): Absolute neutrophil count (ANC) >= 1500 cells/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500/ulXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3 obtained =< 14 days prior to registrationXx_NEWLINE_xXAbsolute Neutrophil Count >1500 cells/mm3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3; blood transfusion to meet the inclusion criteria will not be allowedXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500/mm^3 (obtained =< 7 days prior to randomization)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 mLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3 obtained =<14 days prior to randomizationXx_NEWLINE_xXAbsolute neutrophil count >= 1500/mLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/mm^3 based on complete blood count (CBC)/differential obtained within 21 days prior to study registrationXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >=1500/mLXx_NEWLINE_xXAbsolute neutrophil count ?1500/?LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3; blood transfusion to meet the inclusion criterion will not be allowedXx_NEWLINE_xXPeripheral absolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1500/µLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count of < 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500Xx_NEWLINE_xXAbsolute Neutrophil Count ? 1500/mm3Xx_NEWLINE_xXParticipants with an absolute neutrophil count (ANC) < 1500 cells/mm^3 at time of screening evaluation; growth factor may not be used to meet ANC eligibility criteria within 7 days of obtaining screening evaluationXx_NEWLINE_xXAbsolute neutrophil count (ANC) greater than or equal to 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 / uLXx_NEWLINE_xXWithin 30 days prior to initiation of protocol treatment: Absolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXObtained within 14 days prior to the first study treatment (cycle 1, day 1); absolute neutrophil count (ANC) ? 1500 cells/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/mm^3 or >= 1.5 bil/LXx_NEWLINE_xXAbsolute neutrophil count > 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/ul (without growth factor support)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mcl (filgrastim [G-CSF] is allowed) (must be within 7 days of MLA)Xx_NEWLINE_xXGranulocyte count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/mm^3 or >= 1.5 bil/LXx_NEWLINE_xXGranulocyte count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/mm^3 or >= 1.5 bil/LXx_NEWLINE_xXAbsolute neutrophil count of more than or equal to 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1500/?LXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) or absolute granulocyte count (AGC) >= 1500 per uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500/mcLXx_NEWLINE_xXObtained within 2 weeks from study entry: Absolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophils count >= 1500/mclXx_NEWLINE_xXAbsolute neutrophil count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) =< 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells per mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXObtained =< 7 days prior to registration: Absolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uL, without cerebrospinal fluid (CSF) supportXx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1500/mLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/ulXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3 without colony stimulating factor supportXx_NEWLINE_xXAbsolute neutrophil count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (>= 1500/mm^3) may be supported by transfusion and/or hematopoetic growth factorsXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mcLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mlXx_NEWLINE_xXWithin 14 days prior to registration: Absolute neutrophil count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1500 cells/mm3Xx_NEWLINE_xXAbsolute neutrophil count >= 1500/uL within 30 days prior to registrationXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (>= 1500 per mm^3)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/uL (obtained within 14 days prior to the first study treatment [course 1, day 1])Xx_NEWLINE_xXAbsolute neutrophil count ANC ?1.5 x 109/L (?1500/mm3)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (> 1500 per mm^3), obtained within 14 days prior to first treatmentXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1500/?L (without intervention, e.g., G-CSF)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (>= 1500 per mm^3)Xx_NEWLINE_xXAbsolute neutrophil count less than 1500 per microliter.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mLXx_NEWLINE_xXAbsolute neutrophil count ? 1500/mm3Xx_NEWLINE_xXAbsolute neutrophil count of > 1500 per microliterXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500/ulXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/mm^3Xx_NEWLINE_xXAn absolute granulocyte count > 1500/µLXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1500/mm3 (?1.5× 109/L).Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1500/mlXx_NEWLINE_xXAbsolute-neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1500 (1.5 × 109/L) cells/mm3;Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXHematological: absolute neutrophil count (ANC) ?1500 cells/mm^3, platelet ? 100,000 cells/mm^3, hemoglobin ? 9.0 g/dLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) must be >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500 cells/mm^3, platelet > 100,000 cells/mm^3, hemoglobin > 9 g/dLXx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1500/?LXx_NEWLINE_xXAbsolute neutrophil count >= 1500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500Xx_NEWLINE_xXAbsolute Neutrophil Count (ANC) ? 1500 cells/mm3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (1500/mm^3)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/ulXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3 without colony stimulating factor supportXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9/L (1500/mm^3)Xx_NEWLINE_xXAbsolute neutrophil count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1500/µL (? 1.5 x 103/µL)Xx_NEWLINE_xXAn absolute neutrophil count of more than or equal to 1500/mm^3Xx_NEWLINE_xXTREATMENT: Absolute neutrophil count greater than 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/mm3 without growth factor supportXx_NEWLINE_xXSELUMETINIB ARM: Absolute neutrophil count (ANC) < 1.5 x 10^9/L (1500 per mm^3)Xx_NEWLINE_xXAbsolute neutrophil count >= 1500 neutrophils/mm^3Xx_NEWLINE_xXWithin 14 days prior to first study treatment: Absolute neutrophil count (ANC) >= 1500/10^9 dLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1500 neutrophils/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1500/mm3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/mm^3Xx_NEWLINE_xXAbsolute Neutrophil Count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count ? 1500/mm3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1500 cells/mm3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500/mclXx_NEWLINE_xXAbsolute neutrophil count 1500 cells/mm3 (1.5 x 109/L)Xx_NEWLINE_xXANC >1500 cells/mm3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1500 cells/mm3;Xx_NEWLINE_xXAbsolute neutrophil count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1500 cells/mm3.Xx_NEWLINE_xXAbsolute neutrophil count (ANC) < 1500 / mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1500/?L and platelet count ? 75,000/?L.Xx_NEWLINE_xXAbsolute neutrophil count of 1500 or greaterXx_NEWLINE_xXAbsolute neutrophil count ? 1500/mm3Xx_NEWLINE_xXDoes the subject have an absolute neutrophil count (ANC) ? 1500/mm3?Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/?L obtained =< 7 days prior to registrationXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3 (filgrastim [G-CSF] is allowed)Xx_NEWLINE_xXNeutrophil count of > 1500 cell/mm^3Xx_NEWLINE_xXAn absolute neutrophil count (ANC) > 1500/ulXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count ? 1500 cells/mm3.Xx_NEWLINE_xXAbsolute neutrophil count > 1500/mm^3Xx_NEWLINE_xXCohort A: Absolute neutrophil count greater than 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3 without colony stimulating factor supportXx_NEWLINE_xXAbsolute neutrophil count >= 1500/ulXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1500/µLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3 (1.5 x 10^9/L) (participants receiving transfusion, erythropoietin, or myeloid growth factor support will be eligible for this study)Xx_NEWLINE_xXAbsolute Neutrophil Count ? 1500/mm3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1500 cells/mm^3Xx_NEWLINE_xXabsolute neutrophil count > 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolut neutrophil count (ANC) > 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 mm^-3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1.5 x 10^9 /L (>= 1500 per mm^3)Xx_NEWLINE_xXAbsolute neutrophil count greater than 1500/mm^3 without transfusion or cytokine supportXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 mm^-3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) 1500/mm^3; blood transfusion to meet the inclusion criteria will not be allowedXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500 mm^3 for 14 days prior to registrationXx_NEWLINE_xXAbsolute neutrophil count (ANC) >=1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500Xx_NEWLINE_xXAbsolute neutrophil count < 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/uL (obtained within 28 days prior to the first study treatment)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500/ulXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500, unless felt to be secondary to underlying mantle cell lymphomaXx_NEWLINE_xXAbsolute neutrophil count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count >= 1500/uLXx_NEWLINE_xXAbsolute neutrophil count < 1.5 x 10^9/L (1500/mm^3)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute Neutrophil Count ? 1500/ mm3Xx_NEWLINE_xXAbsolute neutrophil count greater than 1500/mm^3Xx_NEWLINE_xXObtained within 28 days prior to registration: Absolute neutrophil count (ANC) >= 1500 cells/uLXx_NEWLINE_xXTotal granulocyte count of > 1500Xx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) >= 1500 cells/uLXx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500 cells/uLXx_NEWLINE_xXPeripheral absolute neutrophil count (ANC) >= 1500/mm^3Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1500/mm3 (?1.5×109/L)Xx_NEWLINE_xXAbsolute neutrophil count (ANC) > 1500/ulXx_NEWLINE_xXAbsolute neutrophil count (ANC) greater than or equal to (>=) 1500 per cubic millimeter (/mm^3).Xx_NEWLINE_xXAbsolute neutrophil count (ANC) ?1500/mm3 (?1.5 × 103/uL)Xx_NEWLINE_xX